Core Scientific stock falls over 5% as technical selling pressure fuels downside momentum

Traders Union
All News
Financial News
Core scientific slides 5.21% today

Highlights

Core Scientific faces sustained selling pressure after a 5.21% decline to $22.27 and now trades below key short-term moving averages.
Technical indicators signal persistent downside momentum, with weak trend strength and sellers dominating intraday activity near session lows.
Key levels to watch are resistance at $22.29 and support at $20.71, with an expected five-day range of $20.3 to $24.24.

Anton Kharitonov, expert at Traders Union, views Core Scientific's technical downside as a warning. He notes that the sustained breach of both the 20- and 50-day moving averages, alongside a session low close, reflects growing risk aversion and lack of buy support. Absence of relevant news flow further underscores weak sentiment, as the decline appears to stem from internal market fragility rather than external drivers. The convergence of a bearish RSI, negative CCI, and momentum oscillators indicates that sellers remain firmly in control. "Without a material catalyst, I see little reason to trust any rebound here — staying defensive is the priority until buyers reclaim key levels," Kharitonov says.

Viktoras Karapetjanc, expert at Traders Union, sees the recent decline in Core Scientific as a tactical reset within a still-bullish longer-term framework. He points out that the price remains above the 200-day moving average, maintaining the overall positive market structure. The current lack of negative news offers stability, suggesting that broader positioning and sector flows are intact. Karapetjanc believes that consolidation near $22.29 creates a potential launchpad for further growth. "With bullish structure intact and no adverse headlines, I expect buyers to step in soon and target higher levels," he asserts.

Jainam Mehta, market strategist, takes a scenario-based approach given the recent volatility. He observes that momentum indicators support further short-term weakness, but attention should be paid to the $20.71 support for tactical entries. The current sideways consolidation suggests potential for either a quick reversal or a bearish extension if support breaks. "A contrarian setup could emerge on a washout below $20.71, so I would watch for failed breakdowns as a tactical opportunity," Mehta concludes.

Short-term pressure dominates as sellers control key support zone

Core Scientific is trading below its 20-day and 50-day moving averages at $26.05 and $25.22, while remaining above the 200-day moving average at $19.4. This positioning indicates near-term and medium-term pressure from sellers, although the long-term trend remains constructive with a bullish alignment between MA-50 and MA-200; immediate attention is on the $22.29 near-term ceiling and $20.71 near-term floor. The Relative Strength Index (RSI) is low at 42.95 and signals downside momentum, supported by weak readings from the MACD and Average Directional Index (ADX), both forecasting "Sell". The Commodity Channel Index (CCI) also leans negative and the Bull/Bear Power (BBP) value of -0.28 confirms that sellers lead intraday momentum, with a flag for oversold conditions. The stock has declined to $22.27, dropping 5.21% after an opening downside gap of about $0.60 (2.55%); currently, it is positioned near the session low, and intraday volatility stands at 3.45%. Momentum indicators agree with today's sell pressure and persistent weakness after the open.

Earlier, analysts noted that Core Scientific was experiencing persistent technical selling pressure amid a generally bullish long-term backdrop. The current deepening of downside momentum, alongside a buildup in intraday volatility, highlights the importance of monitoring for a potential breakdown below $20.71 support, which could open up increased short-term downside risk.

Source of Data: CORZ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.